| EMAG system
Model/Catalog Number: 418591/418591U
Product Description: Nucleic acid sample preparation instrument IVD, automatedZ-0301-2027 · JJH | BioMerieux SA | Recall | Oct 27, 2026FDA classification date |
| MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO SystemZ-0084-2022 · OUG | BioMerieux SA | Recall | Oct 8, 2021FDA record creation date |
| MYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission of results by transferring, storing,…Z-2225-2021 · N/A | BioMerieux SA | Recall | Aug 6, 2021FDA record creation date |
| NucliSENS Magnetic Extraction ReagentsZ-0218-2019 · PPM | BioMerieux SA | Recall | Oct 23, 2018FDA record creation date |
| VIDAS FSH, Ref 30407-01, IVD, Rx. The firm name on the label is bioMerieux SA, France.
For use on the instruments of the VIDAS family (VITEK Im…Z-2331-2018 · CGJ | BioMerieux SA | Recall | Jun 29, 2018FDA classification date |
| The VITEK 2 Gram-Positive identification card (GP) is intended for use with the VITEK 2 Systems for the automated identification of most signific…Z-2164-2018 · LQL | BioMerieux SA | Recall | Jun 12, 2018FDA record creation date |
| The VITEK 2 Neisseria-Haemophilus identification card (NH) is intended for use with the VITEK 2 Systems for the automated identification of most …Z-2165-2018 · JST | BioMerieux SA | Recall | Jun 12, 2018FDA record creation date |
| The VITEK 2 Anaerobic and Corynebacteria identification card (ANC) is intended for use with the VITEK 2 Systems for the automated identification …Z-2166-2018 · JSP | BioMerieux SA | Recall | Jun 12, 2018FDA record creation date |
| The VITEK 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determ…Z-2167-2018 · LON | BioMerieux SA | Recall | Jun 12, 2018FDA record creation date |
| The VITEK 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determ…Z-2168-2018 · LON | BioMerieux SA | Recall | Jun 12, 2018FDA record creation date |
| VIDAS TOXO IgG Avidity is an automated qualitative test for use on the VIDAS family instruments, for the determination of anti-toxoplasma IgG avi…Z-2169-2018 · LGD | BioMerieux SA | Recall | Jun 12, 2018FDA record creation date |
| The PREVI Color Gram dyes are used with the PREVI Color Gram instrument to stain bacterial and fungal microorganisms for direct examination, acco…Z-2170-2018 · KPA | BioMerieux SA | Recall | Jun 12, 2018FDA record creation date |
| Color Gram 2 (COLOR GRAM 2 - F), these stains are used to stain bacterial and fungal microorganisms for direct examination, according to the Gram…Z-2171-2018 · JTS | BioMerieux SA | Recall | Jun 12, 2018FDA record creation date |
| Oxidase Reagent (ref: 55635): This test is used to detect the production of the enzyme cytochrome oxidase by bacteria. This enzyme is characteris…Z-2172-2018 · JTO | BioMerieux SA | Recall | Jun 12, 2018FDA record creation date |
| ETEST OXACILLIN OX 256 US F100
In vitro diagnostic, a quantitative technique for determining the antimicrobial susceptibility of bacteria spe…Z-0264-2018 · JWY | BioMerieux SA | Recall | Dec 19, 2017FDA classification date |
| ETEST OXACILLIN OX 256 WW F100
In vitro diagnostic, a quantitative technique for determining the antimicrobial susceptibility of bacteria spec…Z-0265-2018 · JWY | BioMerieux SA | Recall | Dec 19, 2017FDA classification date |
| NucliSENS Lysis Buffer
Extended lot for RES 76675Z-0086-2018 · PPM | BioMerieux SA | Recall | Nov 9, 2017FDA record creation date |
| ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging
ETEST is a quantitative technique for determining the antimicrobial susceptibility…Z-2095-2017 · JWY | BioMerieux SA | Recall | May 3, 2017FDA classification date |
| Ceftriaxone TX 32 US S30, Ref 412302 and Ceftriaxone TX 32 US F100, Ref 507058
ETEST is a quantitative technique for determining the antimicro…Z-2126-2017 · JWY | BioMerieux SA | Recall | May 3, 2017FDA classification date |
| ETEST Ceftazidime TZ256 Foam packaging, Product Name: ETEST Ceftazidime TZ 0.016-256.
ETEST is a quantitative technique for determining the antim…Z-1521-2017 · JWY | BioMerieux SA | Recall | Mar 21, 2017FDA classification date |
| ETEST Cephalotin CE 256 Foam packaging, Product Name: ETEST Cephalothin CE 0.016-256.
ETEST is a quantitative technique for determining the antim…Z-1522-2017 · JWY | BioMerieux SA | Recall | Mar 21, 2017FDA classification date |
| ETEST Ceftriaxone TXL32 SPB, Product Name: ETEST Ceftriaxone TX 0.002-32(low).
ETEST is a quantitative technique for determining the antimicrobia…Z-1523-2017 · JWY | BioMerieux SA | Recall | Mar 21, 2017FDA classification date |
| Ciprofloxacin CI 32 Foam packaging, Product Name: ETEST Ciprofloxacin CI 0.002-32.
ETEST is a quantitative technique for determining the antimicr…Z-1524-2017 · JWY | BioMerieux SA | Recall | Mar 21, 2017FDA classification date |
| ETEST Vancomycin VA 256 FOAM packaging, Product Name: ETEST Vancomycin VA 0.016-256.
ETEST is a quantitative technique for determining the antimi…Z-1525-2017 · JWY | BioMerieux SA | Recall | Mar 21, 2017FDA classification date |
| ETEST Doripenem DOR32 FOAM packaging, Product Name: Etest Doripenem DOR 0.002-32.
ETEST is a quantitative technique for determining the antimicr…Z-1526-2017 · JWY | BioMerieux SA | Recall | Mar 21, 2017FDA classification date |